Varegacestat dosing study in healthy adults
This early-stage study tests how the body absorbs and processes a new drug called varegacestat in healthy people. Researchers will compare different ways of giving the drug to understand how well it works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 55 years old and in good overall health
- Have a body mass index (BMI) between 18 and 32, and weigh more than 110 pounds
- Have not smoked or used any nicotine products for at least 3 months
- Not be pregnant or planning to become pregnant, and follow contraception guidelines if male
- Be able to swallow multiple capsules without difficulty
- Have no significant medical conditions, including heart, liver, kidney, blood clotting, or autoimmune diseases
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study tests how a new experimental medicine moves through and leaves the body in healthy volunteers. Researchers will compare different forms of the medicine to understand which works best and is safest.
This trial tests a single dose of a new medicine called HB0056 in healthy volunteers to evaluate its safety and how the body processes it. If you are a healthy adult, you may help doctors understand if this drug is safe for future studies.
This early-phase trial tests an experimental oral medication called FB-101 in healthy adult men to check its safety and how the body processes it. It's a first step to see if the drug is safe enough for future studies in patients.
This early-phase trial tests VV913 capsules in healthy men to see how safe they are and how the body processes the drug. It may help find the right dose for future studies.
This is an early-stage safety study testing a new experimental drug called REGN22044 in people with no serious health conditions. Researchers want to understand how safe the drug is, how well people tolerate it, and how the body processes it.
This trial tests a new drug (VB19055) in healthy volunteers to see how safe it is and how the body processes it. Participants will be watched closely and may help find the right dose for future studies.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.